Journal of Medical Economics
@jme-journal.bsky.social
Open access, medical economics journal. Publishing leading studies that determine the cost-effectiveness of treatment and high-quality economic assessments. Impact Factor: 3.0 and CiteScore: 4.4 (2024)
Access the journals homepage -> http://bit.ly/3I4GZvn
Access the journals homepage -> http://bit.ly/3I4GZvn
𝐍𝐞𝐰 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
Our latest article forecasts the #burden and #healthcarecosts of obesity in the US from 2023 to 2060. It also identifies strategic intervention windows for obesity treatments to maximise cost savings.
Click the link to read the full article 👉 bit.ly/48TDwuR
#HEOR #Healtheconomics
Our latest article forecasts the #burden and #healthcarecosts of obesity in the US from 2023 to 2060. It also identifies strategic intervention windows for obesity treatments to maximise cost savings.
Click the link to read the full article 👉 bit.ly/48TDwuR
#HEOR #Healtheconomics
October 27, 2025 at 11:14 AM
𝐍𝐞𝐰 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
Our latest article forecasts the #burden and #healthcarecosts of obesity in the US from 2023 to 2060. It also identifies strategic intervention windows for obesity treatments to maximise cost savings.
Click the link to read the full article 👉 bit.ly/48TDwuR
#HEOR #Healtheconomics
Our latest article forecasts the #burden and #healthcarecosts of obesity in the US from 2023 to 2060. It also identifies strategic intervention windows for obesity treatments to maximise cost savings.
Click the link to read the full article 👉 bit.ly/48TDwuR
#HEOR #Healtheconomics
🚨 𝐍𝐨𝐰 𝐨𝐧𝐥𝐢𝐧𝐞 🚨
Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. See the graphical abstract below for an overview of the study.
Click the link for the full article 👉 bit.ly/4g3dLJQ
Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. See the graphical abstract below for an overview of the study.
Click the link for the full article 👉 bit.ly/4g3dLJQ
September 3, 2025 at 9:58 AM
🚨 𝐍𝐨𝐰 𝐨𝐧𝐥𝐢𝐧𝐞 🚨
Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. See the graphical abstract below for an overview of the study.
Click the link for the full article 👉 bit.ly/4g3dLJQ
Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. See the graphical abstract below for an overview of the study.
Click the link for the full article 👉 bit.ly/4g3dLJQ
📢 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝𝐢𝐧𝐠
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
August 27, 2025 at 3:52 PM
📢 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝𝐢𝐧𝐠
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
Excited to be attending ISPOR Annual in Montreal, reach out if you are attending too and would like to connect!
#ispor2025 #ispor #heor #healtheconomics #outcomesresearch
#healthpolicy #medicaleconomics #pharmacoeconomics
#ispor2025 #ispor #heor #healtheconomics #outcomesresearch
#healthpolicy #medicaleconomics #pharmacoeconomics
April 29, 2025 at 2:20 PM
Excited to be attending ISPOR Annual in Montreal, reach out if you are attending too and would like to connect!
#ispor2025 #ispor #heor #healtheconomics #outcomesresearch
#healthpolicy #medicaleconomics #pharmacoeconomics
#ispor2025 #ispor #heor #healtheconomics #outcomesresearch
#healthpolicy #medicaleconomics #pharmacoeconomics
🚨Journal news🚨
We are delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research.
We are excited to work with Ishveen to support her career.
We are delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research.
We are excited to work with Ishveen to support her career.
April 2, 2025 at 11:19 AM
🚨Journal news🚨
We are delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research.
We are excited to work with Ishveen to support her career.
We are delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research.
We are excited to work with Ishveen to support her career.
🚨Essential read🚨
The 𝙅𝙤𝙪𝙧𝙣𝙖𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙀𝙘𝙤𝙣𝙤𝙢𝙞𝙘𝙨 𝙧𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝟮𝟬𝟮𝟰, which consists of the journal's 𝐭𝐨𝐩 𝐟𝐢𝐯𝐞 𝐦𝐨𝐬𝐭 𝐯𝐢𝐞𝐰𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬 and Editor in Chief 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬, which he picked for their innovation and impact.
To read the article in full click the link 👉 bit.ly/4jEZRzd
#HEOR #Healtheconomics
The 𝙅𝙤𝙪𝙧𝙣𝙖𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙀𝙘𝙤𝙣𝙤𝙢𝙞𝙘𝙨 𝙧𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝟮𝟬𝟮𝟰, which consists of the journal's 𝐭𝐨𝐩 𝐟𝐢𝐯𝐞 𝐦𝐨𝐬𝐭 𝐯𝐢𝐞𝐰𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬 and Editor in Chief 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬, which he picked for their innovation and impact.
To read the article in full click the link 👉 bit.ly/4jEZRzd
#HEOR #Healtheconomics
March 19, 2025 at 9:48 AM
🚨Essential read🚨
The 𝙅𝙤𝙪𝙧𝙣𝙖𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙀𝙘𝙤𝙣𝙤𝙢𝙞𝙘𝙨 𝙧𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝟮𝟬𝟮𝟰, which consists of the journal's 𝐭𝐨𝐩 𝐟𝐢𝐯𝐞 𝐦𝐨𝐬𝐭 𝐯𝐢𝐞𝐰𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬 and Editor in Chief 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬, which he picked for their innovation and impact.
To read the article in full click the link 👉 bit.ly/4jEZRzd
#HEOR #Healtheconomics
The 𝙅𝙤𝙪𝙧𝙣𝙖𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙀𝙘𝙤𝙣𝙤𝙢𝙞𝙘𝙨 𝙧𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝟮𝟬𝟮𝟰, which consists of the journal's 𝐭𝐨𝐩 𝐟𝐢𝐯𝐞 𝐦𝐨𝐬𝐭 𝐯𝐢𝐞𝐰𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬 and Editor in Chief 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬, which he picked for their innovation and impact.
To read the article in full click the link 👉 bit.ly/4jEZRzd
#HEOR #Healtheconomics
🎉Delighted to share our first plain language summary of publication on #transcatheteraorticvalvereplacement.
Click the link to view the article in full 👉 bit.ly/3Fq36L2
Want to find out more about this article type, let me know: mike.gregg@tandf.co.uk
#plsp #HEOR #healtheconomics #plainlanguage
Click the link to view the article in full 👉 bit.ly/3Fq36L2
Want to find out more about this article type, let me know: mike.gregg@tandf.co.uk
#plsp #HEOR #healtheconomics #plainlanguage
March 17, 2025 at 3:01 PM
🎉Delighted to share our first plain language summary of publication on #transcatheteraorticvalvereplacement.
Click the link to view the article in full 👉 bit.ly/3Fq36L2
Want to find out more about this article type, let me know: mike.gregg@tandf.co.uk
#plsp #HEOR #healtheconomics #plainlanguage
Click the link to view the article in full 👉 bit.ly/3Fq36L2
Want to find out more about this article type, let me know: mike.gregg@tandf.co.uk
#plsp #HEOR #healtheconomics #plainlanguage